Abstract Details

Title LEGATO: Early Rapid Clinical Benefit with Azilect[reg] (Rasagiline Tablets) as Mono- and Adjunct Therapy on Parkinson's Disease (PD) Symptoms - A Multicenter Phase IV Trial

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 030

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Ronald Wilson, MD (Brentwood Neurology)	No disclosure on file
Lauren Seeberger, MD, FAAN	Dr. Seeberger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocine Biosciences. Dr. Seeberger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Seeberger has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Seeberger has received research support from Neurocrine. The institution of Dr. Seeberger has received research support from TEVA.
Dee E. Silver, MD (COASTAL NEUROLOGICAL MED)	No disclosure on file
Alida F. Griffith, MD (Evergreen Health)	No disclosure on file
Jill B. Conner, PhD, MS	No disclosure on file
Phyllis M. Salzman, PhD	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��